Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey
| Autor: | Zhenhui Lu, Chang Liu, Feng Xia, Rongshou Zheng, Ying-Jian Liang, Yijun Yang, Wenling Wang, Rui Mao, Zhiwen Luo, Suxia Luo, Shida Yan, Minshan Chen, Jianqiang Cai, Xiaoying Wang, Zhiyu Li, Qinggang Hu, Jian Zhou, Dong Yan, Jing Tan, Yi Ba, Jianjun Zhao, Xuewen Zhang, Xun Li, Yujun Xie, Xiaofeng Zhu, Bo Chen, Bixiang Zhang, Qichen Chen, Feng Zhang, Aimin Yue, Dianrong Xiu, Xu Che, Hong Zhao, Muxing Li, Yajin Chen, Liming Wang, Jianguo Zhou, Yubao Zhang, Feng Shen, Yamin Zhang, Yue Han, Qingdong Li, Aiping Zhou, Duo Li, Yanqiao Zhang, Tao Peng, Mingyan He, Xuejun Zhang, Xiaowei Dang, Xueli Bai, Xinyu Bi, Caifeng Gong, Wenqiang Wei, Tingbo Liang, Ning Li, Zusen Wang, Yilei Mao, Zhen Huang, Tianqiang Song, Ping Yue, Xiao Chen, Rui Zhang, Lianxin Liu, Changzhen Shang, Yuan Tang, Yong Zeng, Xiujun Cai, Po Yang, Yefan Zhang, Bin Liu, Yongkun Sun, Jing Jin |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Carcinoma Hepatocellular medicine.medical_treatment MEDLINE Computer-assisted web interviewing Targeted therapy Surveys and Questionnaires Pandemic Medicine Humans Chemoembolization Therapeutic Transcatheter arterial chemoembolization Pandemics Response rate (survey) Hepatology business.industry SARS-CoV-2 Liver Neoplasms Gastroenterology COVID-19 Workload medicine.disease Hepatocellular carcinoma Emergency medicine Original Article business |
| Zdroj: | HPB : The Official Journal of the International Hepato Pancreato Biliary Association |
| ISSN: | 1477-2574 1365-182X |
| Popis: | Background This study aimed to investigate the work status of clinicians in China and their management strategy alteration for patients with hepatocellular carcinoma (HCC) during the COVID-19 pandemic. Methods A nationwide online questionnaire survey was conducted in 42 class-A tertiary hospitals across China. Experienced clinicians of HCC-related specialties responded with their work status and management suggestions for HCC patients during the pandemic. Results 716 doctors responded effectively with a response rate of 60.1%, and 664 were included in the final analysis. Overall, 51.4% (341/664) of clinicians reported more than a 60% reduction of the regular workload and surgeons declared the highest proportion of workload reduction. 92.5% (614/664) of the respondents have been using online medical consultation to substitute for the “face-to-face” visits. Adaptive adjustment for the treatment strategy for HCC was made, including the recommendations of noninvasive and minimally invasive treatments such as transcatheter arterial chemoembolization for early and intermediate stage. Targeted therapy has been the mainstay for advanced stage and also as a bridge therapy for resectable HCC. Discussion During the COVID-19 pandemic, online medical consultation is recommended to avoid social contact. Targeted therapy as a bridge therapy is recommended for resectable HCC considering the possibility of delayed surgery. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|